- Raised $30M Series E led by Neopharm Group, Oct 2025
- Raised $6M Series F led by Eldan Neopharm, Feb 2026
- Raised $14M Series D led by Rapha Capital, Nov 2024
About
FIZE Medical is a medical technology company dedicated to transforming critical care through smarter, real-time fluid management. Their flagship product, the FIZE kUO platform, provides continuous, real-time urine output data to enhance kidney function monitoring and early detection of acute kidney injury (AKI). The company aims to transform fluid management in critical care settings by integrating digital analytics, AI algorithms, and seamless EMR system integration, ultimately improving clinical decision-making and patient safety. Their technology helps clinicians detect AKI earlier, optimize fluid balance, and enhance patient safety. FIZE Medical's devices, such as iUO, iUO PLUS, iUO DUOFLO, FIZE kUO PLUS, and FIZE dUO, allow nursing staff to measure and record urine output, sending automatic warnings to doctors when the catheter is clogged or urine production falls below trigger levels. This improves early diagnosis and treatment of AKI, sepsis, and other critical events. FIZE Medical is a commercial-stage company expanding its geographical reach to the U.S., EU, and Asian markets.
Funding history · 7 rounds · $72.7M total
Headcount over time
Q&A
- What is FIZE Medical's primary focus?
- FIZE Medical develops AI-powered fluid management systems for critically ill patients, providing real-time urine output monitoring and early detection of acute kidney injury.
- When was FIZE Medical founded?
- FIZE Medical was founded in 2011.
- How many employees does FIZE Medical have?
- FIZE Medical has 51-200 employees.
- Which investors participated in FIZE Medical's December 2024 Series A round?
- In December 2024, Rapha Capital Management and Valitas Venture Capital led a Series A funding round for FIZE Medical.
- What is the total amount of funding FIZE Medical has raised to date?
- FIZE Medical has raised a total of $45,870,000 in funding.
- What is the FIZE kUO platform?
- The FIZE kUO platform provides continuous, real-time urine output data to enhance kidney function monitoring and early detection of acute kidney injury (AKI).
- What is FIZE Medical's current stage of funding?
- FIZE Medical is currently in its Series A funding stage.
- Has FIZE Medical expanded its market reach?
- Yes, FIZE Medical is a commercial-stage company expanding its geographical reach to the U.S., EU, and Asian markets.
Team · 1
Sectors & technology
Highlights
Tags
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | fizemedical.com/ |
|---|---|
| linkedin.com/company/65312656 |
Identifiers & details
| Legal name | FIZE MEDICAL Ltd. |
|---|---|
| Founded | 2011 |
| Employees (exact) | 30 |
Radar intelligence
Patents
| EPO | 2 |
|---|
Web history (Wayback)
| Domain | fizemedical.com |
|---|
Certificate / subdomain footprint
| Subdomains | 19 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 514606342 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2011-04-14 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | yes |
| Last annual report | 2022 |
| Active charges / liens | 0 |
| Registry events | 5 — shares_capital (5) |
| Registered address | השדרה המרכזית 15 מודיעין-מכבים-רעות |
Recent registry events
| Date | Event |
|---|---|
| 2026-03-18 | שינוי בהרכב הון - מניות-הפחתת הון מוקצה |
| 2026-04-09 | הקצאת מניות |
| 2026-04-09 | העברת מניות |
| 2026-01-05 | שינוי בהרכב הון - מניות-הפחתת הון רשום |
| 2026-01-05 | הגדלה של הון רשום |